Text this: Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer

  _____      ___     __   _     ______    ______  
 /  ___||   / _ \\  | || | ||  /_   _//  /_   _// 
| // __    | / \ || | '--' ||   -| ||-     | ||   
| \\_\ ||  | \_/ || | .--. ||   _| ||_    _| ||   
 \____//    \___//  |_|| |_||  /_____//  /__//    
  `---`     `---`   `-`  `-`   `-----`   `--`